• 1
    Westall GP, Michaelides A, Williams TJ, Snell GI, Kotsimbos TC. Post lung transplant bronchiolitis obliterans syndrome and early human cytomegalovirus DNAaemia dynamics. Transplantation 2003; 75: 20642068.
  • 2
    Estenne M, Maurer JR, Boehler A et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002; 21: 297310.
  • 3
    Trulock EP, Edwards LB, Taylor DO, Boucek MM, Keck BM, Hertz MI. The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult lung and heart-lung transplant report-2004. J Heart Lung Transplant 2004; 23: 804815.
  • 4
    Tikkanen JM, Kallio FA, Bruggeman CA, Koskinen PK, Lemstrom KB. Prevention of cytomegalovirus infection-enhanced experimental obliterative bronchiolitis by anti-viral prophylaxis or immunosuppression in rat tracheal allografts. Am J Respir Crit Care Med 2001; 164: 672679.
  • 5
    Westall GP, Michaelides A, Williams TJ, Snell GI, Kotsimbos TC. Human cytomegalovirus load in plasma and bronchoalveolar lavage fluid: a longitudinal study of lung transplant recipients. J Infect Dis 2004; 190: 10761083.
  • 6
    Gutierrez CA, Chaparro C, Krajden M, Winton T, Kesten S. Cytomegalovirus viremia in lung transplant recipients receiving ganciclovir and immune globulin. Chest 1998; 113: 924932.
  • 7
    Brehm MA, Markess TG, Daniels KA, Greiner DL, Rossini AA, Welsh RM. Direct visualization of cross-reactive effector and memory allo-specific CD8 T cells generated in response to viral infections. J Immunol 2003; 170: 40774086.
  • 8
    Nett PC, Heisey DM, Fernandez LA, Sollinger HW, Pirsch JD. Association of cytomegalovirus disease and acute rejection with graft loss in kidney transplantation. Transplantation 2004; 78: 10361041.
  • 9
    Chemaly RF, Yen-Lieberman B, Chapman J et al. Clinical utility of cytomegalovirus viral load in bronchoalveolar lavage in lung transplant recipients. Am J Transplant 2005; 5: 544548.
  • 10
    Kotsimbos ATC, Sinickas V, Glare EM et al. Quantitative detection of human cytomegalovirus DNA in lung transplant recipients. Am J Respir Crit Care Med 1997; 156: 12411246.
  • 11
    Altman JD, Moss PA, Goulder PJ et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 1996; 274: 9496.
  • 12
    Jung T, Schauer C, Heusser C, Neuman C, Rieger C. Detection of intracellular cytokines by flow cytometry. J Immunol Methods 1993; 159: 197207.
  • 13
    Wills MR, Carmichael AJ, Mynard K et al. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J Virol 1996; 70: 75697579.
  • 14
    Elkington R, Walker S, Crough T et al. Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers. J Virol 2003; 77: 52265240.
  • 15
    Sewell WA, North ME, Webster AD, Farrant J. Determination of intracellular cytokines by flow-cytometry following whole blood-culture. J Immunol Methods 1997; 209: 6774.
  • 16
    Michaelides AE, Facey D, Spelman DW, Wesselingh SL, Kotsimbos TC. HCMV DNA detection and quantitation in the plasma and PBL of lung transplant recipients: Cobas Amplicor HCMV monitor test versus in-house quantitative HCMV PCR. J Clin Virol 2003; 28: 111120.
  • 17
    Hamann D, Baars PA, Rep MH et al. Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med 1997; 186: 14071418.
  • 18
    Ghaneker SA, Nomura Le, Suni MA, Picker LJ, Maecker HT, Maino VC. Gamma interferon expression in CD8(+) T cells is a marker for circulating cytotoxic T lymphocytes that recognize an HLA A2-restricted epitope of human cytomegalovirus phosphoprotein pp65. Clin Diagn Lab Immunol 2001; 8: 628631.
  • 19
    Gamadia LE, Remmerswaal EB, Weel JF, Bemelman F, Van Lier RA, Ten Berge TJ. Primary immune responses to human CMV disease: a critical role for IFN-γ-producing CD4+ T cells in protection against CMV disease. Blood 2003; 101: 26862692.
  • 20
    Bowden RA, Digel J, Reed EC, Meyers JD. Immunosuppressive effects of ganciclovir on in vitro lymphocyte responses. J Infect Dis 1987; 156: 899903.
  • 21
    Sester U, Gartner BC, Wilkens H et al. Differences in CMV-specific T cell levels and long-term susceptibility to CMV infection after kidney, heart and lung transplantation. Am J Transplant 2005; 5: 14831489.
  • 22
    Zinkernagel RM, Doherty PC. Restriction of in vitro T cell mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 1974; 248: 701702.
  • 23
    D'Ambrosio D, Mariani M, Panina-Bordignon P, Sinigaglia F. Chemokines and their receptors guiding T lymphocyte recruitment in lung inflammation. Am J Respir Crit Care Med 2001; 164: 12661275.
  • 24
    Spencer H, Rampling D, Aurora P, Bonnet D, Hart SL, Jaffe A. Transbronchial biopsies provide longitudinal evidence for epithelial chimerism in children following sex mismatched lung transplantation. Thorax 2005; 60: 6062.
  • 25
    Elkington R, Khanna R. Cross-recognition of human allo-antigen by cytomegalovirus glycoprotein-specific CD4+ cytotoxic lymphocytes: implications for graft-versus-host disease. Blood 2005; 105: 13621364.
  • 26
    Burrows SR, Khanna R, Silins SL, Moss DJ. The influence of antiviral T-cell responses on the alloreactive repertoire. Immunol Today 1999; 20: 203207.
  • 27
    Masopust D, Vezys V, Marzo AL, Lefrancois L. Preferential localization of effector memory cells in non-lymphoid tissue. Science 2001; 291: 24132417.
  • 28
    Appay V, Dunbar PR, Callan M et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002; 8: 379385.
  • 29
    Tomiyami H, Takata H, Matsuda T, Takiguchi M. Phenotypic classification of human CD8+ T cells reflecting their function: inverse correlation between quantitative expression of CD27 and cytotoxic effector function. Eur J Immunol 2004; 34: 9991010.
  • 30
    Gamadia LE, Van Leeuwen EM, Remmerswaal EB et al. The size and phenotype of virus-specific T cell populations is determined by repetitive antigenic stimulation and environmental cytokines. J Immunol 2004; 172: 61076114.
  • 31
    Razonable RR. Epidemiology of cytomegalovirus disease in solid organ and hematopoietic stem cell transplant recipients. Am J Health Syst Pharm 2005; 62: S7S13.
  • 32
    Pawelec G, Akbar A, Caruso C, Grubeck-Loebenstein B, Solana R, Wikby A. Human immunosenescence: is it infectious? Immunol Rev 2005; 205: 257268.